ACI's 44th FDA Bootcamp

Bindu Donovan will be speaking on a panel, “IP Overview for Drugs and Biologics: Patents, Trademarks, Orange Book, and Exclusivities – Part 1,” at the 44th U.S. Food and Drug Administration (FDA) Bootcamp, hosted by the American Conference Institute (ACI).

The ACI FDA Boot Camp brings together life sciences attorneys, industry executives, and policy leaders to gain a clear, practical understanding of how the FDA is operating today, cutting through regulatory uncertainty to navigate approvals, enforcement risk, and emerging technologies with confidence in a rapidly shifting regulatory landscape.

For more information about the conference, please visit the ACI website.